Significant Spacecraft Anomalies

Related by string. * sig nificant . signifi cant . Signifi cant : statistically significant differences . statistically significant improvement . demonstrated statistically significant / spacecrafts . SPACECRAFT . spacecraft : robotic spacecraft . aboard Soyuz spacecraft . Russian Soyuz spacecraft / ANOMALIES . anomalies : EM anomalies . soil geochemical anomalies . sediment anomalies * *

Related by context. Frequent words. (Click for all words.) 51 hematologic toxicity 50 elotuzumab 50 subgroup analyzes 50 TranSwitch indebtedness 50 By Susan Sandys 49 obj obj = 49 CIM definitions 49 Bid increments 49 By Jason Samenow 49 Drill intersections 48 QTc prolongation 48 adecatumumab 48 stringer mineralization 47 GLJ Report 47 nonclinical studies 47 Metallurgical testwork 47 proration factor 47 accreted value 47 dirucotide 47 AZX# 47 secondary efficacy endpoints 47 dose cohorts 47 sensitivity specificity 47 Allovectin 7 ® 47 vismodegib 46 efficacy endpoint 46 updated Mineral Resource 46 Prefeasibility Study 46 Entereg R 46 anti leukemic 46 NLX P# 46 estimated metallurgical recoveries 46 ganetespib 46 PROPEL trial 46 El Quevar project 46 Significant assay 46 BY JASON CHEN 46 Therein lurks 46 Triolex 46 #.#mln rub [001] 45 By Claire McNeilly 45 By Ben Geman 45 dose limiting toxicities 45 unrounded 45 NEUMUNE 45 Phase IIa clinical trials 45 tanespimycin 45 tecarfarin 45 assessment PEA 45 OTTI charges 45 HICP inflation 45 Phase Ib II 45 sonographic findings 45 heavily pretreated patients 45 resource estimation 45 SAR# [004] 45 TOLAMBA 45 teriflunomide 44 CPIF 44 outturns 44 xi fluctuating currency 44 By DEALBOOK 44 HGS ETR2 44 eU#O# 44 hypoglycemic events 44 #.#bn rub [003] 44 CR# vcMMAE 44 BrachySil 44 Earning Per Share 44 intersegment revenues 44 axitinib 44 By JOY LEIKER 44 tumor resection 44 Tavocept 44 Bankable Feasibility Study BFS 44 Eugene Puritch P.Eng 44 QT prolongation 44 Phase IIb trials 44 inferred resource estimate 44 World J Gastroenterol 44 Blended ARPU 44 nominal 44 #.#/BOE [002] 44 RGB # 43 TELCYTA 43 dose titration 43 PXD# 43 Prospectus Offer 43 #,#,#,# equity shares [001] 43 NI #-# Mineral Resource 43 multivariate logistic regression 43 #.# crore [002] 43 updated NI #-# 43 SF CDOs 43 incentive accruals 43 tolerability profiles 43 Phase 2a trial 43 #.#pps [002] 43 placebo controlled clinical trials 43 phase IIa clinical 43 By FRED KERBER

Back to home page